Sinotherapeutics Inc. (SHA:688247)
China
· Delayed Price · Currency is CNY 10.25
-0.12 (-1.16%)
Mar 13, 2025, 4:00 PM CST
Sinotherapeutics Revenue
In the year 2024, Sinotherapeutics had annual revenue of 512.69M CNY with 70.97% growth. Sinotherapeutics had revenue of 150.08M in the quarter ending December 31, 2024, with 73.49% growth.
Revenue
512.69M
Revenue Growth
+70.97%
P/S Ratio
9.44
Revenue / Employee
1.97M
Employees
260
Market Cap
4.75B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Aier Eye Hospital Group | 20.62B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |